Moreover, Murdaca et al. [54] reported a possible role for the IL-33/IL-31 axis in autoimmune diseases, where both cytokines cooperate in synergistic biological mechanisms in disease onset and progression, suggesting that these cytokines could be potential therapeutic targets. This evidence concerns the gene IL31 and autoimmune disease.